Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
7,801,755
-
Share change
-
+2,876,965
-
Total reported value
-
$98,413,816
-
Price per share
-
$12.60
-
Number of holders
-
28
-
Value change
-
+$36,390,248
-
Number of buys
-
14
-
Number of sells
-
6
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2025
As of 31 Dec 2025,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,801,755 shares.
The largest 10 holders included
Assenagon Asset Management S.A., Allspring Global Investments Holdings, LLC, Phocas Financial Corp., SG Americas Securities, LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Oliver Luxxe Assets LLC, NorthCrest Asset Manangement, LLC, Stonebridge Financial Group, LLC, Kendall Capital Management, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.